英文名称
                            6-Desacetyl-6-Bromo Palbociclib
                            
                            
                            6-溴-8-环戊基-5-甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]吡啶并[2,3-d]嘧啶-7(8H)-酮
                             
                        
                        
                        
                        
                            纯度
                            
                                >95% (HPLC)
                                
                                    网页展示纯度为入库指导纯度值,各批次间存在一定差异,实际纯度以收货为准
                             
                            
                            
                         
                        
                        
                        
                            
                                
                                Off-White to Yellow Solid
Aqueous Acid (Slightly), DMSO (Slightly, Heated), DMF (Slightly, Heated)
 
                        
                     
                    
                        
                            
                            
                                Standards; Pharmaceutical/API Drug Impurities/Metabolites;
                            
                         
                     
                    
                        
                            
                            
                                6-Desacetyl-6-Bromo Palbociclib is an impurity of Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.Also, it is derived from 6-Bromo-2-chloro-8-cyclopentyl-5-methylpyrido-[2,3-d]pyrimidin-7(8H)-one (B682195), which is used to prepare pyridino[2,3-d]pyrimidin-7(8H)-one derivatives as CDK4 and/or CDK6 inhibitors useful in the treatment of diseases.